Trends in the use of inhaled corticosteroids for childhood asthma in New Zealand

European Journal of Clinical Pharmacology

Volumn 59, Issue 5-6, 2003, Pages 483-487

  Johansson, Maria ^a   Hall, Jason ^b   Reith, David ^b,c   Jackson, Pare ^b   Tilyard, Murray ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c DUNEDIN HOSPITAL   (New Zealand)

Author keywords

Childhood asthma; Inhaled corticosteroids

Indexed keywords

BECLOMETASONE; BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE;

ADOLESCENT; ARTICLE; ASTHMA; CHILD; CONTROLLED STUDY; DATA BASE; DRUG POTENCY; FEMALE; HUMAN; INFANT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; MEDICAL RESEARCH; NEW ZEALAND; NEWBORN; PRESCRIPTION; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENAL CORTEX HORMONES; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; ASTHMA; BECLOMETHASONE; BUDESONIDE; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG UTILIZATION REVIEW; HUMANS; INFANT; INFANT, NEWBORN; NEW ZEALAND; RETROSPECTIVE STUDIES;

EID: 0141594683     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-003-0659-2     Document Type: Article

References (27)

1. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee (1998) Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 351:1225-1232
2. Rasmussen F, Taylor DR, Flannery EM, Cowan JO, Greene JM, Herbison GP, et al (2002) Risk factors for hospital admission for asthma from childhood to young adulthood: a longitudinal population study. J Allergy Clin Immunol 110:220-227
3. Asher MI, Barry D, Clayton T, Crane J, D'Souza W, Ellwood P, et aI (2001) The burden of symptoms of asthma, allergic rhinoconjunctivitis and atopic aczema in children and adolescents in six New Zealand centres: ISAAC Phase One. N Z Med J 114:114-120
4. Hall J, Martin I (2002) Paediatric prescribing in New Zealand. NZFP 29:14-18
5. Gustafsson P, Tsanakas J, Gold M, Primhak R, Radford M, Gillies E (1993) Comparison of the efficacy and safety of inhaled fluticasone propionate 200 ug/day with inhaled beclomethasone dipropionate 400 ug/day in mild and moderate asthma. Arch Dis Child 69:206-211
6. Barnes NC, Hallett C, Harris TA (1998) Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less. Respir Med 92:95-104
7. Karadoc F, Karadag B, Kut A, Ersu R, Bakac S, Cebeci D, et al (2001) A comparison of the efficacy and safety of a half dose of fluticasone propionate with beclomethasone dipropionate and budesonide in childhood asthma. J Asthma 38:229-237
8. Fitzgerald D, Van Asperen P, Mellis C, Honner M, Smith L, Ambler G (1998) Fluticasone propionate 750 ug/day versus beclomethasone dipropionate 1500 ug/day: comparison of efficacy and adrenal function in paediatric asthma. Thorax 53:656-661
9. Ferguson AC, Spier S, Manjra A, Versteegh FG, Mark S, Zhang P (1999) Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide. J Pediatr 134:422-427
10. Demedts M, Cohen R, Hawkinson R (1999) Switch to non-CFC inhaled corticosteroids: a comparative efficacy study of HFA-BDP and CFC-BDP metered-dose inhalers. Int J Clin Pract 53:331-338
11. Hall J, Penrose A, Tomlin A, Reid J (2003) Differential prescribing of inhaled corticosteroids in New Zealand general practice. N Z Med J 116:(in press)
12. Black PN, Lawrence B J, Goh KH, Barry MS (2000) Differences in the potencies of inhaled steroids are not reflected in the doses prescribed in primary care in New Zealand. Eur J Clin Pharmacol 56:431-435
13. Adams N, Bestall JM, Jones PW (2002) Fluticasone versus beclomethasone or budesonide for chronic asthma. Cochrane Database Syst Rev 1:CD002310
14. Holt S, Suder A, Weatherall M, Cheng S, Shirtcliffe P, Beasley R (2001) Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis. BMJ 323:1-8
15. Adams N, Bestall JM, Jones PW (2002) Inhaled fluticasone at different doses for chronic asthma. Cochrane Database Syst Rev 1:CD003534
16. Hofstra WB, Neijens HJ, Duiverman EJ, Kouwenberg JM, Mulder PG, Kuethe MC, et al (2000) Dose-responses over time to inhaled fluticasone propionate treatment of exercise- and methacholine-induced bronchoconstriction in children with asthma. Pediatr Pulmonol 29:415-423
17. Pedersen S, Hansen OR (1995) Budesonide treatment of moderate and severe asthma in children: a dose-response study. J Allergy Clin Immunol 95:29-33
18. Bisgaard H, Gillies J, Groenewald M, Maden C (1999) The effect of inhaled fluticasone propionate in the treatment of young asthmatic children: a dose comparison study. Am J Respir Crit Care Med 160:126-131
19. Drake AJ, Howells RJ, Shield JP, Prendiville A, Ward PS, Crowne EC (2002) Symptomatic adrenal insufficiency presenting with hypoglycaemia in children with asthma receiving high dose inhaled fluticasone propionate. BMJ 324:1081-1083
20. Sharek PJ, Bergman DA (2000) The effect of inhaled steroids on the linear growth of children with asthma: a meta-analysis. Pediatrics 106:E8
21. Van Asperen P, Mellis CM, Sly PD (2002) The role of corticosteroids in the management of childhood asthma. Med J Aust 176:169-174
22. Dovey SM, Tilyard MW (1996) The computer research network of the Royal New Zealand College of General Practitioners: an approach to general practice research in New Zealand. Br J Gen Pract 46:749-752
23. Pethica BD, Penrose A, MacKenzie D, Hall J, Beasley R, Tilyard M (1998) Comparison of potency of inhaled beclomethasone and budesonide in New Zealand: retrospective study of computerised general practice records. BMJ 317:986-990
24. Russell G (1994) Fluticasone propionate in children. Respir Med 88[Suppl A]:25-29
25. Summary of product characteristics: flixotide inhaler 25 mcg: Glaxo Wellcome UK Ltd; 13 August 2001
26. Lipworth BJ (1999) Systemic adverse effects of inhaled corticosteroid therapy. Arch Intern Med 159:941-955
27. Barnes PJ, Jonsson B, Klim JB (1996) The costs of asthma. Eur Respir J 9:636-642